XBI
State Street SPDR S&P Biotech ETF
📎 Investment Objective
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
Overview
ETF tracking State Street SPDR S&P Biotech ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
🎯 Investment Strategy
The fund employs a passive management approach, seeking to track the performance of the underlying index. The index includes domestic companies from the biotechnology industry that meet certain size, liquidity, and other criteria.
✨ Key Features
- Provides exposure to the broad biotechnology industry through a diversified portfolio of stocks
- Passively managed to track the performance of the S&P Biotechnology Select Industry Index
- Low expense ratio of 0.00%
- Suitable for investors seeking broad healthcare/biotech sector exposure
⚠️ Primary Risks
- Concentration risk as the fund is focused on the biotechnology industry
- Volatility risk as the biotech sector can experience significant price swings
- Liquidity risk for some of the smaller, less-traded component stocks
- Regulatory and patent-related risks that can impact the biotechnology industry
👤 Best For
This ETF may be suitable for investors with a long-term investment horizon who are looking for diversified exposure to the biotechnology sector and can tolerate the higher volatility associated with this industry. It may be appropriate as a satellite holding within a broader, diversified portfolio.
Top Holdings
| Rank | Ticker | Name | Weight | Sector |
|---|---|---|---|---|
| 1 | RNA | AVIDITY BIOSCIENCES INC | 2.50% | - |
| 2 | RVMD | REVOLUTION MEDICINES INC | 2.36% | - |
| 3 | INSM | INSMED INC | 2.14% | - |
| 4 | REGN | REGENERON PHARMACEUTICALS | 2.05% | - |
| 5 | EXAS | EXACT SCIENCES CORP | 2.03% | - |
| 6 | BBIO | BRIDGEBIO PHARMA INC | 2.01% | - |
| 7 | INCY | INCYTE CORP | 2.00% | - |
| 8 | AMGN | AMGEN INC | 1.98% | - |
| 9 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.96% | - |
| 10 | ROIV | ROIVANT SCIENCES LTD | 1.96% | - |
| 11 | NTRA | NATERA INC | 1.94% | - |
| 12 | UTHR | UNITED THERAPEUTICS CORP | 1.91% | - |
| 13 | BIIB | BIOGEN INC | 1.89% | - |
| 14 | EXEL | EXELIXIS INC | 1.84% | - |
| 15 | VRTX | VERTEX PHARMACEUTICALS INC | 1.83% | - |